Approvals/TGA/APRETUDE cabotegravir 600 mg/3 mL prolonged-release suspension for injection vial

Approved

STANDARD

APRETUDE cabotegravir 600 mg/3 mL prolonged-release suspension for injection vial

ViiV Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 64ffdd32cd5c9216
Product Name: APRETUDE cabotegravir 600 mg/3 mL prolonged-release suspension for injection vial
Artg Id: 377474
Artg Name: APRETUDE cabotegravir 600 mg/3 mL prolonged-release suspension for injection vial
Sponsor: ViiV Healthcare Pty Ltd
Company Detail Path: /organization/viiv-healthcare-pty-ltd
Artg Date: 2022-08-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/dd7c54c7d7a582a925e6fb5bfd086728.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/6ffb93ccc46350b53298326d00e78dd5.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

64ffdd32cd5c9216

Type

Standard